Detalhe da pesquisa
1.
A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia.
Blood
; 123(9): 1302-8, 2014 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24381226
2.
CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab.
Eur J Haematol
; 93(1): 77-80, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24528507
3.
Combined use of multiday palonosetron with aprepitant and low-dose dexamethasone in prevention of nausea and emesis among patients with multiple myeloma and lymphoma undergoing autologous hematopoietic stem cell transplant: A pilot study.
J Oncol Pharm Pract
; 20(4): 263-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24005093
4.
Cancer survivorship in hematologic malignancies: Lifestyle changes after diagnosis.
Cancer Med
; 10(3): 1066-1073, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33527779
5.
Is there a plateau in the survival curve after autologous transplantation in patients with intermediate and high-risk acute myeloid leukemia? A 20-year single institution experience.
Leuk Res
; 31(9): 1253-7, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17320953
6.
A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution.
Mil Med
; 167(7): 541-5, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12125844
7.
Kaposi sarcoma after non-myeloablative hematopoietic stem cell transplant: response to withdrawal of immunosuppressant therapy correlated with whole blood human herpesvirus-8 reverse transcriptase-polymerase chain reaction levels.
Leuk Lymphoma
; 54(10): 2299-302, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23343181
8.
Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura.
Ann Hematol
; 84(4): 232-5, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15517266
9.
Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
Ann Hematol
; 84(8): 526-31, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15915350